Form 4: Axon Director Sells Shares Under 10b5-1 Plan

Axon Enterprise Director Jeri Williams sold 157 shares of common stock for $490 per share under a pre-arranged 10b5-1 trading plan.

Summary

• Director Jeri Williams of Axon Enterprise, Inc. sold 157 shares of common stock.
• The sale occurred on March 17, 2026, at a price of $490 per share.
• The transaction was executed under a Rule 10b5-1 trading plan established on December 8, 2025.
• Following the sale, Jeri Williams directly owns 1,159 shares of Axon common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event because the sale was conducted under a pre-arranged 10b5-1 plan, which typically indicates a planned liquidity event rather than a reaction to new, adverse information.

Positives

• The sale was conducted under a pre-arranged Rule 10b5-1 trading plan, indicating it was not based on new, non-public information.

Negatives

• A director sold 157 shares of common stock, which reduces their direct ownership in the company.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider sales, even those under 10b5-1 plans, are routinely monitored by investors for insights into management's perspective on future stock performance, though 10b5-1 plans mitigate the immediate negative signal.

Stakeholder Impact

• Shareholders: The sale slightly reduces director ownership, but the 10b5-1 plan context suggests it is not a signal of lack of confidence in the company's future.

Key Dates

Recommendation

The insider sale was conducted under a pre-arranged 10b5-1 plan, which is a common practice for executives to manage personal finances and diversify holdings. This type of transaction typically does not signal a change in the company's fundamental outlook or management's confidence, thus a 'hold' recommendation is appropriate based solely on this filing.

Keywords

Axon Enterprise, AXON, Jeri Williams, Insider Sale, Form 4, 10b5-1 Plan, Director Transaction, Equity Sale